MSD Partners as of Sept. 30, 2017
Portfolio Holdings for MSD Partners
MSD Partners holds 33 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 67.8 | $2.3B | 9.2M | 251.23 | |
| Macquarie Infrastructure Company | 4.6 | $156M | 2.2M | 72.18 | |
| Altaba | 4.5 | $155M | 2.3M | 66.24 | |
| Ss&c Technologies Holding (SSNC) | 3.1 | $107M | 2.7M | 40.15 | |
| Coty Inc Cl A (COTY) | 2.9 | $98M | 5.9M | 16.53 | |
| Nexstar Broadcasting (NXST) | 2.5 | $87M | 1.4M | 62.30 | |
| Apollo Global Management 'a' | 2.0 | $67M | 2.2M | 30.10 | |
| Restaurant Brands Intl Inc Com equity / large cap (QSR) | 1.8 | $60M | 941k | 63.88 | |
| Halozyme Therapeutics (HALO) | 1.1 | $39M | 2.2M | 17.37 | |
| Cedar Fair | 1.1 | $39M | 601k | 64.12 | |
| Liberty Media Corp Series C Li | 1.1 | $38M | 1.0M | 38.09 | |
| Ring Energy (REI) | 1.1 | $38M | 2.6M | 14.49 | |
| Hrg | 1.0 | $33M | 2.1M | 15.61 | |
| National Gen Hldgs | 0.7 | $22M | 1.2M | 19.11 | |
| ZIOPHARM Oncology | 0.6 | $21M | 3.4M | 6.14 | |
| SPDR S&P Oil & Gas Explore & Prod. | 0.6 | $21M | 600k | 34.09 | |
| Blueknight Energy Partners | 0.5 | $19M | 3.3M | 5.70 | |
| Novagold Resources Inc Cad (NG) | 0.5 | $17M | 4.2M | 4.12 | |
| Tribune Co New Cl A | 0.4 | $15M | 365k | 40.86 | |
| Stealthgas (GASS) | 0.4 | $12M | 3.7M | 3.31 | |
| Interpublic Group of Companies (IPG) | 0.3 | $11M | 523k | 20.79 | |
| Marten Transport (MRTN) | 0.3 | $10M | 500k | 20.55 | |
| Bmc Stk Hldgs | 0.3 | $10M | 482k | 21.35 | |
| JPMorgan Chase & Co. (JPM) | 0.2 | $7.2M | 75k | 95.51 | |
| Citigroup (C) | 0.2 | $7.1M | 98k | 72.74 | |
| Ez (EZPW) | 0.2 | $6.8M | 715k | 9.50 | |
| Synthetic Biologics | 0.1 | $3.8M | 4.1M | 0.93 | |
| Fibrocell Science | 0.1 | $2.1M | 693k | 3.06 | |
| Egalet | 0.0 | $1.4M | 1.1M | 1.28 | |
| Oragenics Inc New C ommon | 0.0 | $725k | 1.7M | 0.42 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $394k | 25k | 15.76 | |
| Nabriva Therapeutics | 0.0 | $410k | 50k | 8.20 | |
| Ampliphi Biosciences | 0.0 | $14k | 15k | 0.93 |
